These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 28655067)
1. Fatal ulcerative enteritis of the small intestine in a patient with ulcerative colitis treated with vedolizumab. Monasterio C; Schmitt-Gräff A; Pohl M; Truschel T; Warnatz K; Kreisel W; Thimme R; Hasselblatt P Z Gastroenterol; 2017 Oct; 55(10):1014-1020. PubMed ID: 28655067 [TBL] [Abstract][Full Text] [Related]
2. Vedolizumab for ulcerative colitis and Crohn's disease: results and implications of GEMINI studies. Lam MC; Bressler B Immunotherapy; 2014; 6(9):963-71. PubMed ID: 25341118 [TBL] [Abstract][Full Text] [Related]
3. Effects of Anti-Integrin Treatment With Vedolizumab on Immune Pathways and Cytokines in Inflammatory Bowel Diseases. Rath T; Billmeier U; Ferrazzi F; Vieth M; Ekici A; Neurath MF; Atreya R Front Immunol; 2018; 9():1700. PubMed ID: 30131801 [TBL] [Abstract][Full Text] [Related]
4. Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents. Iborra M; Beltrán B; Maroto N; Navarro-Cortés P; Boscá-Watts M; Ferrer-Bradley I; García-Morales N; Sáez-González E; Hinojosa J; Mínguez M; Nos P Gastroenterol Hepatol; 2018 Nov; 41(9):535-543. PubMed ID: 30031573 [TBL] [Abstract][Full Text] [Related]
5. The safety of vedolizumab for the treatment of ulcerative colitis. Novak G; Hindryckx P; Khanna R; Jairath V; Feagan BG Expert Opin Drug Saf; 2017 Apr; 16(4):501-507. PubMed ID: 28276855 [TBL] [Abstract][Full Text] [Related]
6. Vedolizumab for the treatment of ulcerative colitis. Stallmach A; Schmidt C; Teich N Expert Rev Gastroenterol Hepatol; 2016; 10(2):165-75. PubMed ID: 26588993 [TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamic assessment of vedolizumab for the treatment of ulcerative colitis. McLean LP; Cross RK Expert Opin Drug Metab Toxicol; 2016 Jul; 12(7):833-42. PubMed ID: 27096357 [TBL] [Abstract][Full Text] [Related]
8. Vedolizumab for the treatment of ulcerative colitis. Shahidi N; Bressler B; Panaccione R Expert Opin Biol Ther; 2016; 16(1):129-35. PubMed ID: 26567768 [TBL] [Abstract][Full Text] [Related]
9. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine. Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138 [TBL] [Abstract][Full Text] [Related]
11. Effect of vedolizumab (anti-α4β7-integrin) therapy on histological healing and mucosal gene expression in patients with UC. Arijs I; De Hertogh G; Lemmens B; Van Lommel L; de Bruyn M; Vanhove W; Cleynen I; Machiels K; Ferrante M; Schuit F; Van Assche G; Rutgeerts P; Vermeire S Gut; 2018 Jan; 67(1):43-52. PubMed ID: 27802155 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of vedolizumab in the treatment of ulcerative colitis. Domènech E; Gisbert JP Gastroenterol Hepatol; 2016 Dec; 39(10):677-686. PubMed ID: 26948838 [TBL] [Abstract][Full Text] [Related]
13. Vedolizumab-associated pulmonary manifestations in children with ulcerative colitis. Cucinotta U; Dipasquale V; Costa S; Pellegrino S; Ramistella V; Romano C J Clin Pharm Ther; 2022 Feb; 47(2):254-256. PubMed ID: 34278581 [TBL] [Abstract][Full Text] [Related]